Selamectin 220119-17-5 — China API Manufacturer | USP/BP R&D to Production

China Manufacturing Landscape for Selamectin

Selamectin (CAS 220119-17-5) is a semi-synthetic avermectin derivative widely used in veterinary medicine as a topical antiparasitic agent effective against fleas, heartworm, ear mites, and intestinal parasites in companion animals. China has emerged as a leading global manufacturing hub for Selamectin API, driven by the country’s established fermentation and semi-synthetic modification capabilities inherited from decades of avermectin and ivermectin production. Our production facility specializes in large-scale Selamectin production for export to veterinary pharmaceutical formulators across North America, Europe, Latin America, and the Asia-Pacific region.

The Chinese veterinary API manufacturing sector benefits from a complete domestic supply chain for avermectin-class compounds, with fermentation-derived precursors, chemical modification reagents, and chromatographic purification media all sourced locally. This supply chain autonomy translates directly into pricing advantages and production flexibility that international customers use for their own competitive positioning in increasingly cost-sensitive companion animal health markets.

Manufacturing Process & Facility

Selamectin production begins with large-scale fermentation of Streptomyces avermitilis to produce doramectin or avermectin B1 as the starting material, followed by a series of semi-synthetic chemical modification steps including selective oxime formation, catalytic hydrogenation, and monosaccharide manipulation to achieve the target molecular structure. The fermentation is conducted in stainless steel bioreactors ranging from 5,000 to 50,000 liters capacity, with computer-controlled temperature, dissolved oxygen, pH, and nutrient feed profiles optimized through decades of process development.

Post-fermentation processing involves solvent extraction, multi-stage chromatographic purification using both normal-phase and reverse-phase silica systems, and controlled crystallization to yield pharmaceutical-grade Selamectin with the required polymorphic characteristics. The facility operates under China NMPA veterinary standards with cleanroom environments maintained at ISO Class 8 for fermentation areas and ISO Class 7 for chemical modification and final isolation suites. Annual capacity stands at 2,000 kg with expansion capability.

Quality Standards & Multi-Pharmacopeial Compliance

Our Selamectin API meets or exceeds USP and BP pharmacopeial specifications, with HPLC purity consistently above 97.0% and individual related substance levels controlled within monograph limits. The isomer ratio (Selamectin B2a to B1a) is carefully controlled through process parameters to ensure batch-to-batch consistency that formulators require for stable topical solution manufacturing. Identity confirmation is performed by IR spectroscopy, mass spectrometry, and comparison against qualified reference standards.

Complete testing protocols include assay by validated HPLC, residual solvents by headspace GC, heavy metals by ICP-MS, microbial limits testing, water content by Karl Fischer, and specific optical rotation measurement. All analytical methods are validated per ICH Q2(R1) guidelines. Stability data generated under ICH veterinary guidelines supports a 36-month retest period when stored under recommended conditions.

Regulatory Documentation

Complete regulatory documentation packages are provided to support customer filings in all major veterinary pharmaceutical markets. Documentation includes Veterinary Drug Master Files (VDMF), Certificates of Analysis with full impurity and isomer profiling, quality certificates, TSE/BSE-free declarations, and detailed manufacturing process descriptions in CTD Module 3 format. For EU market registrations, we provide EDQM-compatible documentation and support CEP applications. Customers targeting the US market receive FDA-compatible VMF documentation with full process validation data and analytical method validation reports.

Packaging & Logistics

Selamectin API is packaged in amber-colored pharmaceutical-grade HDPE containers with inert gas overlay to protect against photodegradation and oxidation, available in 500 g, 1 kg, 5 kg, and 10 kg configurations. All packaging is validated for long-term stability compatibility. Shipments are dispatched via temperature-controlled air freight from major Chinese hub airports, with cold chain integrity maintained throughout transit. Standard international delivery timelines range from 7-14 business days, with customs clearance documentation including MSDS, veterinary health certificates, and import permit support provided as standard service.

Competitive Pricing & Supply Reliability

Direct competitive pricing for Selamectin reflects our vertically integrated manufacturing model, eliminating trading company margins that inflate costs for end users. We offer tiered pricing for annual contract volumes, project-based quotations for formulation development quantities, and strategic partnership pricing for long-term procurement agreements. Production lead times are typically 6-8 weeks for standard orders, with the ability to accommodate urgent requests within 3-4 weeks through priority scheduling. Our fermentation and synthesis campaigns are planned quarterly, ensuring consistent availability without the supply gaps that characterize single-source procurement strategies.

Selamectin Specifications